Georgia
Provider Communications
Clinical Criteria updates for specialty pharmacy are available
ING-CC-0029 |
Dupixent (dupilumab) |
ING-CC-0035 |
Duopa (carbidopa and levodopa enteral suspension) |
ING-CC-0058 |
Byngezia Pen, Sandostatin, or Sandostatin LAR (Octreotide)/ Octreotide Agents |
ING-CC-0142 |
Somatuline Depot (lanreotide) |
ING-CC-0176 |
Beleodaq (belinostat) |
ING-CC-0188 |
Imcivree (setmelanotide) |
Access the Clinical Criteria document information.
Our prior authorization clinical review of non-oncology specialty pharmacy drugs will be managed by our medical specialty drug review team. Drugs used for the treatment of Oncology will be managed by AIM Specialty Health®* (AIM).
Featured In:
November 2022 Anthem Provider News - Georgia